학술논문

Pegozafermin for the treatment of non-alcoholic steatohepatitis patients with F2/F3 fibrosis: a multi-center, randomized, double-blind, placebo-controlled Phase 2b trial (ENLIVEN)
Document Type
Journal
Source
JOURNAL OF HEPATOLOGY; JUN 2023, 78 pS14-pS15, 2p. Supplement: 1
Subject
Language
English
ISSN
16000641